Cargando…
SLE‐associated myelitis successfully treated by rituximab
Systemic lupus erythematosus (SLE) is an autoimmune disease. Transverse myelitis (TM) is one of the rare neurological manifestations of SLE. Here, we present a case of SLE in which TM precede other symptoms and successfully treated by Rituximab.
Autores principales: | Khabbazi, Alireza, Ghadakchi, Leyla, Yazdani, Yalda, Habibzade, Elham, Mehrtabar, Saba, Khalaji, Amirreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676124/ https://www.ncbi.nlm.nih.gov/pubmed/36419577 http://dx.doi.org/10.1002/ccr3.6622 |
Ejemplares similares
-
Axonal sensory‐motor polyneuropathy in ankylosing spondylitis: A case report
por: Khalaji, Amirreza, et al.
Publicado: (2023) -
Castleman disease presenting as lymphadenopathy in a female with systemic lupus erythematosus: A rare case report
por: Khabbazi, Alireza, et al.
Publicado: (2023) -
SLE - Rituximab in lupus
por: Eisenberg, Robert
Publicado: (2003) -
COVID-19 after rituximab therapy in cSLE patients
por: Nelson, Meghan Corrigan, et al.
Publicado: (2023) -
Use of Rituximab in child with SLE and myocardial involvement
por: Balan, S, et al.
Publicado: (2008)